Feedback / Questions
onilcamotide (RV001) - RhoVac
https://www.prnewswire.com/news-releases/pre-clinical-findings-support-the-potential-use-of-rhovacs-drug-candidate-onilcamotide-across-several-cancers-301550403.html
May 18, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next